Abstract: The embodiments disclose an apparatus including an eyewear pupilometer for detecting, measuring and processing a wearer's pupil movement and size, for detecting and processing retinal images, for detecting and processing a wearer's field of view, for broadcasting alerts, for pre-diagnostic screening, for overriding vehicle operation and for measuring, recording and transmitting circadian responses, at least one eyewear pupilometer module including a lens fiber optic camera module, an image processor module, a retinal image infrared detector module, an outward camera module, at least one alert module, an alert light and message projector, a WI-FI module, an automated pullover module, an automated steering module, fiber optic & data cables, a contact lens pupilometer image, sensor and processor module, and at least one eyewear pupilometer module coupled to and/or embedded into eyewear frames and lenses, contact lenses, a vehicle wind shield and protective covers for hand held devices and laptop computers.

Abstract: The embodiments disclose an apparatus including an eyewear pupilometer for detecting, measuring and processing a wearer's pupil movement and size, for detecting and processing retinal images, for detecting and processing a wearer's field of view, for broadcasting alerts, for pre-diagnostic screening, for overriding vehicle operation and for measuring, recording and transmitting circadian responses, at least one eyewear pupilometer module including a lens fiber optic camera module, an image processor module, a retinal image infrared detector module, an outward camera module, at least one alert module, an alert light and message projector, a WI-FI module, an automated pullover module, an automated steering module, fiber optic & data cables, a contact lens pupilometer image, sensor and processor module, and at least one eyewear pupilometer module coupled to and/or embedded into eyewear frames and lenses, contact lenses, a vehicle wind shield and protective covers for hand held devices and laptop computers.

Abstract: Truck fairings are connected together with a vibration-isolating bracket device. The device includes three parts: two brackets and a strap. The brackets are a lightweight material such as aluminum. The brackets are formed and configured to be coupled together by the strap without the need for further fasteners such as bolts or rivets. The strap is flexible and elastic and provides vibration isolation as well as coupling.

Abstract: A process for forming composite articles includes the steps of delivering resin to a mixer at a pre-set flow rate; mixing the resin with a catalyst in the mixer to form a composite material; delivering a stream of the composite material to a mould; detecting variations in flow rate of the resin during delivery relative to a pre-set value of flow rate of the resin; and controlling delivery of the resin material to reduce the variations in flow rate of the resin during delivery.

Abstract: The present specification relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form.

Abstract: The present specification relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form.

Abstract: The present invention relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form, as a vanilloid.

Abstract: Systems and methods for protecting a series capacitor bank are provided. According to one exemplary embodiment of the invention, there is disclosed a capacitor protection circuit. The capacitor protection circuit may include a capacitor bank, a pilot circuit and a main commutation gap. The pilot circuit and the main commutation gap may be provided in parallel electrical communication with the capacitor bank. Additionally, one or more plasma injectors may be provided in series electrical communication with the pilot circuit. The plasma injectors may be operable to provide partially or completely ionized plasma across the main commutation gap to make conductive the main commutation gap.

Abstract: The present invention relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form, as a vanilloid.

Abstract: The present invention relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form, as a vanilloid.

Abstract: A content delivery system, such as a Just in Time Training (JITT) system which allows the broadcast of multimedia messages to recipients or users. The JITT system identifies the multimedia capabilities as well as the capabilities of the service provider and recipient device for each user and uses this profile information to determine an appropriate messaging format to use to send the message to each user. User involvement is used to determine the functionality and content type delivery for each user mobile device. This profiling may be performed in any of a number of different ways, including smart echo, caller-ID initiated (CIDI) and SMS initiated (SMSI) profiling. In smart echo profiling, the user sends the JITT system a multimedia sample from the mobile device, and the JITT system then sends messages and content to the mobile devise using the same format.

Abstract: The invention provides compounds of formula I wherein n, A, R, R?, R?, RO, X and Y are as defined in the description, and their preparation. The compounds of formula I are useful as pharmaceuticals.

Abstract: Methods and systems for tracking and evaluating social writing activities are discussed. In one example embodiment, a method for tracking and evaluating social writing activities includes operations for monitoring content creation, tracking social behaviors, identifying activities of value, and associating the activities of value with a complex activity. The monitoring content creation can include detecting activities within a social software environment. The tracking social behaviors include tracking behaviors related to the content creation activities performed within the social software environment. The identifying activities of value include identifying activities of value associated with the content creation activities. Finally, associating the activities of value with a complex activity can form a composite picture.

Abstract: Methods and systems for tracking and evaluating review tasks. In one example embodiment, a method for tracking and evaluating review tasks includes operations for defining a review task, receiving a review response, scoring the review response, and storing a review score. The defining a review task can include receiving a plurality of parameters including a review target and a reviewer. The review response can be received from a reviewer and can be associated with the review task. The scoring the review response can include creating a review score for the reviewer. The review score can be stored in association with the reviewer and the review response within a database.

Abstract: The present invention relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form, as a vanilloid.

Abstract: The invention is a discreet patch suitable for use in the treatment of a viral lesion, which patch includes a backing layer and an adhesive layer, where the adhesive layer is substantially free of hydrocolloid particles, and the patch has a thickness ranging from about 10 microns to about 1,500 microns and is substantially free of topical anti-acne agents, and methods for treating viral lesions where a discreet patch of the invention is applied to a viral lesion and maintained in contact therewith for a time effective to substantially complete re-epithelialization of the lesion.

Abstract: An electronic information card generation and transmittal system generates audience member or user initiated electronic information request cards. Such electronic information request cards (EIRCs) enable broadcasters, network operators, advertisers and program producers to capture and take advantage of the impulse purchase urges, as indicated by the generation of an information request, of the audience members for converting those urges into purchases or information sharing. For example, a network provider/broadcaster notifies an audience member of eligibility to participate in the facility of the system. The audience member signs up to participate in the facility by registering the system for that user. Upon viewing or listening to a program or commercial of interest, the audience member initiates an EIRC through a user interface.

Abstract: Systems and methods for protecting a series capacitor bank are provided. According to one exemplary embodiment of the invention, there is disclosed a capacitor protection circuit. The capacitor protection circuit may include a capacitor bank, a pilot circuit and a main commutation gap. The pilot circuit and the main commutation gap may be provided in parallel electrical communication with the capacitor bank. Additionally, one or more plasma injectors may be provided in series electrical communication with the pilot circuit. The plasma injectors may be operable to provide partially or completely ionized plasma across the main commutation gap to make conductive the main commutation gap.

Abstract: The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.